Internal Medicine, Hematology & Oncology · Bronx, NY
NPI
1265559199
Since 2007
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
4487 3rd Ave, Fourth Floor Cancer Center
Bronx, NY, 10457
Phone (718) 960-6377
Groups this clinician bills Medicare through
Medicare paid, 2024
$7,443
88 services
Medicare patients, 2024
47
Average age 68
Drug cost, 2024
$5.5M
1,437 prescriptions
Company payments, 2025
$3,608
From 28 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ilmana Fulger was code 99214 (office e&m - established), 30 times for 18 patients. In total Ilmana Fulger billed 88 services in 10 codes, and Medicare paid $7,443.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2008-07-24.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 30 | 18 | $77.71 | $2,331 |
| 99213 Office E&M - Established | Facility | 19 | 16 | $51.54 | $979 |
| 99222 Hospital E&M - Initial | Facility | 11 | 11 | $116.27 | $1,279 |
By year: 2022 $8,230 for 97 services; 2023 $9,270 for 113 services; 2024 $7,443 for 88 services.
Medicare prescription drug claims, 2024
In 2024, the drug Ilmana Fulger prescribed most often to Medicare patients was Xgeva (Denosumab), with 162 prescriptions and refills. In total Ilmana Fulger wrote 1,437 Medicare prescriptions that cost $5.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Xgeva Denosumab | 162 | 162 | 19 | $499K |
| Letrozole Generic | 84 | 146 | 22 | $1,063 |
| Keytruda Pembrolizumab | 75 | 75 | Under 11 | $881K |
| Warfarin Sodium Generic | 72 | 97 | 18 | $238 |
| Lupron Depot Leuprolide Acetate | 54 | 158 | 18 | $301K |
| Prolia Denosumab | 50 | 300 | 34 | $81K |
| Nubeqa Darolutamide | 44 | 46 | Under 11 | $627K |
| Darzalex Faspro Daratumumab-Hyaluronidase-Fihj | 41 | 41 | Under 11 | $378K |
| Hydroxyurea Generic | 37 | 60 | Under 11 | $1,059 |
| Orgovyx Relugolix | 37 | 39 | Under 11 | $105K |
| Lenalidomide Generic | 32 | 32 | Under 11 | $556K |
| Aranesp Darbepoetin Alfa In Polysorbat | 30 | 30 | Under 11 | $46K |
| Eliquis Apixaban | 22 | 23 | Under 11 | $13K |
| Ondansetron Hcl Generic | 22 | 24 | 16 | $141 |
| Tamoxifen Citrate Generic | 22 | 36 | Under 11 | $561 |
Brand drugs: 737 claims; generic drugs: - claims; opioid claims: 47.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ilmana Fulger $3,608 ($3,608 in general payments such as food, travel and fees) from 28 companies. The largest payer was Novartis Pharmaceuticals Corporation with $355.
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation NVS | 15 | $355 |
| Janssen Biotech, Inc. JNJ | 10 | $289 |
| Pfizer Inc. PFE | 12 | $258 |
| Daiichi Sankyo Inc. 4568.T | 12 | $256 |
| Gilead Sciences, Inc. GILD | 6 | $243 |
| AstraZeneca Pharmaceuticals LP AZN | 10 | $223 |
| GlaxoSmithKline, LLC. GSK | 9 | $217 |
| Genzyme Corporation SNY | 8 | $213 |
| Stemline Therapeutics Inc. | 7 | $158 |
| Eisai Inc. 4523.T | 6 | $149 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.